Literature DB >> 22858927

Natural history of successive COPD exacerbations.

Jadwiga A Wedzicha, Gavin C Donaldson.   

Abstract

Mesh:

Year:  2012        PMID: 22858927     DOI: 10.1136/thoraxjnl-2012-202087

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

1.  Utility of the CAT in the therapy assessment of COPD exacerbations in China.

Authors:  You-Hui Tu; Yan Zhang; Guang-He Fei
Journal:  BMC Pulm Med       Date:  2014-03-11       Impact factor: 3.317

2.  Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate?

Authors:  Omar Kherad; Pierre-Olivier Bridevaux; Laurent Kaiser; Jean-Paul Janssens; Olivier T Rutschmann
Journal:  Open Respir Med J       Date:  2014-04-04

3.  Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.

Authors:  Lucas M A Goossens; Inge Leimer; Norbert Metzdorf; Karin Becker; Maureen P M H Rutten-van Mölken
Journal:  BMC Pulm Med       Date:  2014-10-18       Impact factor: 3.317

4.  Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Maria B Ospina; Marta Michas; Lesly Deuchar; Richard Leigh; Mohit Bhutani; Brian H Rowe; Darcy Marciniuk; Donna Goodridge; Gail Dechman; Jean Bourbeau; Meyer Balter; Pat Camp; Paul Hernandez; Roger S Goldstein; Michael K Stickland
Journal:  BMJ Open Respir Res       Date:  2018-01-30

Review 5.  Pulmonary Embolism in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Yao-Qian Cao; Li-Xia Dong; Jie Cao
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

6.  Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.

Authors:  Kristina Vermeersch; Ann Belmans; Kris Bogaerts; Iwein Gyselinck; Nina Cardinaels; Maria Gabrovska; Joseph Aumann; Ingel K Demedts; Jean-Louis Corhay; Eric Marchand; Hans Slabbynck; Christel Haenebalcke; Stefanie Vermeersch; Geert M Verleden; Thierry Troosters; Vincent Ninane; Guy G Brusselle; Wim Janssens
Journal:  Respir Res       Date:  2019-10-29

7.  Inhaled dsRNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma.

Authors:  I Mahmutovic-Persson; H Akbarshahi; N W Bartlett; N Glanville; S L Johnston; A Brandelius; L Uller
Journal:  Allergy       Date:  2013-11-28       Impact factor: 13.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.